Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host.

Similar presentations


Presentation on theme: "Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host."— Presentation transcript:

1 Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host Disease of the Gastrointestinal Tract  Drew J. Winston, Lindsey R. Baden, Don A. Gabriel, Christos Emmanouilides, Leslie M. Shaw, W. Robert Lange, Voravit Ratanatharathorn  Biology of Blood and Marrow Transplantation  Volume 12, Issue 6, Pages (June 2006) DOI: /j.bbmt Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Mean plasma ganciclovir concentration over time after dosing with 900 mg of oral valganciclovir or 5 mg/kg of intravenous ganciclovir. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Mean plasma valganciclovir concentration over time after dosing with 900 mg of oral valganciclovir. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host."

Similar presentations


Ads by Google